Zee Medical Granted OTC Labeling Exemption For Inactive Ingredients
This article was originally published in The Tan Sheet
Executive Summary
Zee Medical has FDA's permission to use the phrase "may contain" to list inactive ingredients that may or may not be present in its PainAid Pain Relief tablets.
You may also be interested in...
OTC Labeling Exemption, Deferral Timelines Depend On Complexity - FDA
FDA expects to respond to completed OTC labeling exemption and deferral requests that are straightforward or "consistent with previously granted requests" in 30 to 60 days, the agency says.
OTC Labeling Exemption, Deferral Timelines Depend On Complexity - FDA
FDA expects to respond to completed OTC labeling exemption and deferral requests that are straightforward or "consistent with previously granted requests" in 30 to 60 days, the agency says.
Inactive Ingredient "May Contain" Listing Sought By Perrigo
Perrigo is asking FDA to allow it to use the phrase "may contain" to list inactive ingredients on two of its over-the-counter cough/cold products.